Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer

<div>Top list of somatic mutation targets in stage IIIA-N2 NSCLC patients: (a) preoperation; (b) postoperation; (c) postradiochemotherapy.</div>

Disease Markers

Figure 3: Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer 